Presented at the Society of Teachers of Family Medicine (STFM) 2023 annual meeting, the two FDA pivotal studies validated the performance and benefit of the hand-held, non-invasive, optical spectroscopy device in point-of-care skin lesion evaluation. …

DermaSensor’s Non-Invasive Skin Cancer Device Found to Halve the Number of Skin Cancers Not Referred by PCPs Read More »

MIAMI, April 21, 2023, EINPresswire.com — DermaSensor Inc., a health technology company that has developed a non-invasive device to better equip primary care physicians (PCPs) to detect skin cancer, is proud to announce that its …

DermaSensor Recognized as 2023 Edison Silver Award Winner with its FDA Breakthrough Device for Skin Cancer Detection Read More »

Presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting, the FDA-submitted studies mark the first successful pivotal clinical study for any skin cancer detection device for primary care physicians MIAMI, March 17, 2023, …

DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation Read More »

MIAMI, March 03, 2023, EINPresswire.com — DermaSensor Inc., a health technology company that develops non-invasive tools to better equip primary care physicians (PCPs) to detect skin cancer, today announced the appointment of Dr. Jane Grant-Kels …

DermSensor Inc. Announces the Addition of Dr. Jane Grant-Kels to its Scientific Advisory Board Read More »

Company Announces Larry Anderson as Chief Commercial Officer, Dr. Vivien Nguyen as Dir. of Medical Affairs, Ryan Freiden promoted to Chief Operating Officer MIAMI, September 1, 2022, EINPresswire.com — DermaSensor Inc., a health technology company …

DermaSensor Announces Major Hires of Chief Commercial Officer, Director of Medical Affairs, Chief Operating Officer Read More »